ĀÜĄņĀŅĀ×

Dr. Love was a senior scientist at Ciba Geigy/Novartis focused on novel drug delivery technologies and involved in the development of the worldā€™s leading eye-care pharmaceutical, Visudyne. In 1997, Dr. Love founded Destiny Pharma and he is the co-inventor of the XF drug platform. Dr. Love was a founding member of the BEAM Alliance, an EU SME group focused on promoting antimicrobial drug development. He is an expert advisory board member of Global AMR Innovation Fund, appointed by Professor Dame Sally Davies. He joined the UK Research and Innovation (ā€œUKRIā€) COVID-19 Research and Innovation Taskforce in March 2021. Dr. Love is the named inventor in more than 70 patents. He has experience in drug R&D from discovery and lead identification, through pre-clinical development and into Phase 1/2 clinical development in the UK, EU and US.